Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:34 PM
Ignite Modification Date:
2025-12-24 @ 9:34 PM
NCT ID:
NCT00058032
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Postmenopausal, as defined by meeting 1 of the following criteria:
* More than 12 months of amenorrhea after natural menopause or hysterectomy
* Received more than 12 months of hormone replacement therapy for menopausal symptoms
* No prior ovarian malignancy
* No prior bilateral oophorectomy
* Not at high risk for ovarian cancer due to familial predisposition as defined by the UKCCCR Familial Ovarian Cancer Screening Study
PATIENT CHARACTERISTICS:
Age
* 50 to 74
Performance status
* Not specified
Life expectancy
* Not specified
Hematopoietic
* Not specified
Hepatic
* Not specified
Renal
* Not specified
Other
* No active non-ovarian malignancy
* Prior malignancy allowed provided there is no documented persistent or recurrent disease and patient has not received treatment for more than 1 year
PRIOR CONCURRENT THERAPY:
Biologic therapy
* Not specified
Chemotherapy
* Not specified
Endocrine therapy
* See Disease Characteristics
Radiotherapy
* Not specified
Surgery
* See Disease Characteristics
Other
* No concurrent participation in any other ovarian cancer screening study
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
50 Years
Maximum Age:
74 Years
Study:
NCT00058032
Study Brief:
Protocol Section:
NCT00058032